Stay updated on LOU064 Efficacy and Safety in CSU Clinical Trial
Sign up to get notified when there's something new on the LOU064 Efficacy and Safety in CSU Clinical Trial page.

Latest updates to the LOU064 Efficacy and Safety in CSU Clinical Trial page
- Check7 days agoChange DetectedThe NCT03926611 record is displayed with details of Novartis’s completed Phase 2b LOU064 dose-finding study for chronic spontaneous urticaria, including its treatment arms, eligibility criteria, outcome measures, and study documents.SummaryDifference95%

- Check14 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice about NIH websites transitioning from the term “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the full study content. Full study details and linked resources are no longer accessible.SummaryDifference19%

Stay in the know with updates to LOU064 Efficacy and Safety in CSU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LOU064 Efficacy and Safety in CSU Clinical Trial page.